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Abstract: Unplanned hospital readmissions are common early post-
kidney transplantation. We investigated the relationship between early
hospital readmissions and clinical outcomes in a single-center
retrospective study that included all adult kidney transplant patients
between 2004 and 2008 with follow-up to December 2012. The early
hospital readmissions within the ﬁrst 30 d were numbered and the
diagnosis ascertained. Patients were grouped as none, once, and twice or
more readmissions. Predictors of early readmissions were assessed, and
clinical outcomes and patient and death-censored kidney survival were
compared. Among 1064 patients, 203 (19.1%) patients had once and 83
(7.8%) patients had twice or more readmissions within 30 d. Surgical
complications, infections, and acute kidney injuries/acute rejection were
three most common diagnoses. The length of initial hospital stay and
African American race were among the variables associated signiﬁcantly
with readmissions. Patients with early readmissions had lower baseline
renal function (p < 0.01) and more early acute rejection (p < 0.01).
During follow-up, only frequent readmissions, twice or more, within 30 d
were associated with increased risk of death (AHR 1.75, p = 0.01) and
death-censored kidney failure (AHR 2.20, p < 0.01). Frequent early
hospital readmissions post-transplantation identify patients at risk for
poor long-term outcomes, and more studies are needed to understand the
mechanisms.
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Unplanned hospital readmissions following index
medical and/or surgical events are common and
costly (1). Readmissions increase the burden to
patients and their care providers, place patients at
high risk for errors related to transition-of-care,
and likely reﬂect suboptimal patient care (2, 3).
Reducing readmissions through speciﬁc interven-
tions has the potential to both lower the cost asso-
ciated with readmissions and improve clinical
outcomes (4). While researchers have investigated
hospital readmissions following index medical
and/or surgical admissions and/or procedures
among general population, there are relatively few
publications that examined hospital readmissions
among patients undergoing kidney transplantation
(5–7). Early studies have generally focused on the
incidence and the causes of hospital readmissions,
either at 30 d or within the ﬁrst year (5, 8, 9).
There have been only two reports exploring the
association between hospital readmissions with
subsequent clinical outcomes among kidney trans-
plant patients (5, 10).
The need for hospital readmissions early after
kidney transplantation is likely multifactorial and
related, in part, to the transplant procedure itself.
Demographic factors, pre-existent medical and
psychological comorbidities, and pre-transplant
physical conditioning may each interfere with the
recovery process post-transplantation and may
result in the need for early readmission (8, 11–13).
In addition, the requirement for long-term use of
immunosuppressive medications adds to the
uniqueness of this patient population as adverse
eﬀects of immunosuppressants can also lead to
hospital readmissions (12, 14). Further, the fre-
quency of readmissions early post-transplantation
could reﬂect deﬁcits in post-transplant medical
management and thus may be useful in scrutinizing
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standard practice patterns for patients who
undergo kidney transplantation. To this end, we
conducted a single-center retrospective study to
investigate the causes and clinical predictors of
early hospital readmissions within 30 d following
kidney transplantation and to explore the relation-
ship between early hospital readmissions and long-
term clinical outcomes.
Patients and methods
This is a retrospective and single-center observa-
tional study that included all adult kidney trans-
plant recipients engrafted between January 1, 2004
and December 31, 2008 with follow-up to Decem-
ber 31, 2012. The institutional review board
approved the study.
Patients who received simultaneous multi-organ
transplants, who died or lost the kidney graft dur-
ing the initial hospital stay, or who experienced
primary non-function of the graft were excluded.
Demographic and baseline characteristics of the
study population including recipient, donor, and
transplant-related parameters were obtained from
the institutional electronic medical record data-
base. In particular, we identiﬁed the pre-transplant
history of illicit drug and alcohol abuse, chronic
opioid usage, and self-reported psychiatric condi-
tions such as depression, anxiety, etc. among
others during the transplant evaluation process.
Baseline renal function was expressed as estimated
glomerular ﬁltration rate (eGFR) calculated by the
Modiﬁcation of Diet in Renal Disease (MDRD)
four-variable formula using stably achieved lowest
serum creatinine levels (at least three readings in a
two-wk period) within the ﬁrst month after trans-
plantation (15). The occurrence of acute rejection
during the ﬁrst month was documented through
clinically indicated biopsy according to Banﬀ clas-
siﬁcation (16). Finally, the information on death
and graft loss beyond the ﬁrst 30 d was collected
during the follow-up and the causes documented.
The unplanned early readmissions within 30 d
following the transplant surgery were documented
from the institutional electronic medical records
with admission diagnosis veriﬁed using related dis-
charge summaries. The causes of hospital readmis-
sions were grouped into the following categories:
cardiovascular events (CVE), infectious events,
surgical complications, acute kidney injuries/acute
rejection (AKI/AR), ﬂuid and electrolytes (FE)
issues, gastrointestinal (GI) disorders, deep vein
thrombosis (DVT), and others.
We separated the study population into three
groups according to the number of hospital read-
missions within 30 d post-transplantation: none,
once (isolated), and twice or more readmissions
(frequent). We included all baseline patient, donor,
and transplant-related characteristics to assess their
potential association with unplanned readmissions.
We compared the baseline renal function
achieved and the incidence of biopsy-proven acute
rejection among the three groups during the ﬁrst
30 d. We then performed conditional survival
analysis beyond 30 d and considered separately
patient and death-censored kidney survival as
long-term clinical outcomes among the three
groups. We further compared the cause of death
and/or kidney graft loss among the three groups.
The distribution of categorical variables was
expressed as proportions and compared using chi-
square (v2) test, and the measurements of continu-
ous variables were summarized as a mean and
standard deviation and compared using the analy-
sis of variance (ANOVA) test. Multinomial logisti-
cal regression analyses were used to assess
predictors as adjusted odds ratios (AOR) of hospi-
tal readmission: once and twice or more readmis-
sions. All recipient, donor, and transplant-related
characteristics were assessed individually and
included in the multivariate models via a backward
selection. Kaplan–Meier survival curves with log-
rank testing were performed to compare patient
and death-censored graft survival beyond 30 d
among the three groups. Cox regression analyses
were performed to calculate adjusted hazard ratios
(AHR) for the entire cohort groups: all recipient,
donor, and transplant characteristics, as well as
achieved baseline renal function and occurrence of
acute rejection were individually assessed and con-
sidered for inclusion in the multivariate models if
the individual p-value was 0.10 or less. Alterna-
tively, we included all baseline variables in the
models to obtain statistically signiﬁcant associa-
tion. We assessed the potential for multicollinearity
among the baseline variables by visually inspecting
the correlation coeﬃciency between each and indi-
vidual pair of variables. Backward selection
method was employed. A cutoﬀ of 0.05 was used to
individually and independently determine the con-
tribution of such variables to the outcomes.
All statistical tests were two sided, and a p-value
equal to or less than 0.05 was considered signiﬁ-
cant. Statistical analyses were conducted using
SAS 9.3. (Cary, NC, USA).
Results
Study population
During the study period, 1064 kidney transplant
patients met the criteria to be included in the
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analyses. The mean length of follow-up was
64.0  26.8 months and the median 66.1 (50.0,
83.7) months. Overall, 286 (26.9%) patients had a
total of 383 (36.0%) hospital readmissions within
30 d post-transplantation. Among them, 204
(19.2%) patients had one and 82 (7.7%) patients
had twice or more readmissions. The demographic
and baseline characteristics of study population
are shown in Table 1. Mean age of entire study
population was 49.3 (13.2) years old. Median
length of initial hospital stay was 4 (2, 34) days. Six
hundred and sixty-eight subjects were male
(62.8%), and 193 were African American (AA;
18.1%). Patients who required hospital readmis-
sions were more likely to be AA (p < 0.01), to have
longer pre-transplant dialysis time (p < 0.01), less
likely to have pre-emptive (p = 0.03) and/or living
donor kidney transplantation (p < 0.01). Further-
more, these patients had higher prevalence of coex-
isting psychiatric diagnosis (p < 0.01), higher
prevalence for smoking history (p = 0.01), and
were less likely to have private health insurance
(p = 0.01). At the time of transplantation, they
received more often kidneys from expanded crite-
ria donors (ECD; p < 0.01) and donors after car-
diac death (DCD; p < 0.01), had more HLA
mismatches (p < 0.01), experienced more delayed
graft function (DGF; p < 0.01), and required
longer initial inpatient stay (p < 0.01).
Causes and predictors of hospital readmissions
The most common diagnosis justifying early read-
missions was surgical complications accounting for
32.4% of all readmissions, followed by infection
(20.1%), acute kidney injuries/acute rejection
(13.0%), CVE (11.0%), ﬂuid and electrolyte issues
(11.5%), gastrointestinal complaints (5.7%), deep
vein thrombosis (1.3%), and others (5.0%).
Although there were more readmissions related to
Table 1. Demographic and baseline char-
acteristics of study population Hospital readmissions
p
None,
n = 778
Once,
n = 204
Twice or more,
n = 82
Recipient characteristics
Age, yr (SD) 49.2 (13.1) 46.7 (14.0) 49.8 (12.3) 0.88
Gender, male (%) 489 (62.9) 125 (62.7) 54 (65.9) 0.77
Race, African American (%) 126 (16.2) 51 (25.0) 22 (26.8) <0.01
BMI, kg/m2 (SD) 28.4 (5.6) 28.5 (5.6) 29.0 (6.9) 0.67
Dialysis duration, yr (SD) 2.2 (2.6) 3.0 (3.0) 3.3 (3.2) <0.01
Diabetes mellitus, yes (%) 259 (33.3) 82 (42.2) 27 (32.9) 0.17
Smoking history, yes (%) 367 (47.2) 117 (57.4) 49 (59.8) 0.01
Alcohol abuse history, yes (%) 79 (10.2) 23 (11.3) 13 (15.9) 0.28
Drug abuse history, yes (%) 91 (11.7) 25 (12.3) 12 (14.6) 0.73
Chronic opioid use history, yes (%) 71 (9.1) 26 (12.8) 11 (13.4) 0.19
Psychiatric history, yes (%) 216 (27.8) 67 (32.8) 40 (48.8) <0.01
College education, yes (%) 389 (50.0) 90 (44.1) 31 (37.8) 0.05
Private insurance, yes (%) 352 (45.2) 76 (37.3) 24 (29.3) 0.01
Employed, yes (%) 332 (42.7) 79 (38.7) 31 (37.8) 0.46
First transplant, yes (%) 671 (86.3) 176 (86.3) 71 (86.6) 0.99
Pre-emptive transplant, yes (%) 211 (27.1) 43 (21.1) 13 (15.9) 0.03
Positive HCV serology, yes (%) 29 (3.7) 12 (5.9) 7 (8.5) 0.08
PRA, >20% (%) 169 (21.7) 51 (25.0) 15 (18.3) 0.42
Donor characteristics
Age, yr (SD) 39.5 (13.4) 39.8 (12.7) 39.6 (15.6) 0.96
Gender, male (%) 408 (52.4) 99 (48.5) 51 (62.2) 0.11
Living donor, yes (%) 413 (53.1) 84 (41.2) 34 (41.5) <0.01
Expanded criteria donors, yes (%) 83 (10.7) 44 (21.6) 13 (15.9) <0.01
Donors after cardiac death, yes (%) 42 (5.4) 27 (13.2) 8 (9.8) <0.01
Transplant characteristics
HLA mismatches, n (SD) 3.1 (1.9) 3.6 (1.8) 3.5 (1.9) <0.01
Cold ischemia time, hours (SD) 7.7 (6.9) 8.7 (6.7) 8.6 (7.0) 0.14
Delayed graft function, yes (%) 92 (11.8) 45 (22.1) 18 (22.0) <0.01
CMV D+/R, yes (%)
160 (20.6) 34 (16.7) 22 (26.8) 0.15
Calcineurin inhibitors, CsA (%) 718 (92.3) 182 (89.2) 77 (93.3) 0.28
rATG induction, yes (%) 184 (23.7) 46 (22.6) 24 (29.3) 0.47
Initial hospital stay, days (SD) 5.1 (3.3) 6.7 (5.7) 6.5 (4.2) <0.01
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surgical and infectious complications among
patients with frequent early readmissions, the over-
all pattern was similar between patients with iso-
lated and frequent readmissions (Fig. 1). Longer
initial inpatient stay (days), a positive self-reported
psychiatric history, being an AA patient, receiving
an ECD kidney transplant, having higher HLA
mismatches and having a positive smoking history
were variably associated with high likelihood of
readmissions (once and/or twice or more) within
the initial 30 d (Table 2).
Baseline renal function and episodes of acute
rejection during the two time periods
Patients who required early readmissions achieved
signiﬁcantly lower baseline transplant renal func-
tion (eGFR: 61.6  16.1, 57.4  17.1 and
59.1 + 18.4 mL/min, ANOVA, p < 0.01). Simi-
larly, patients with early readmissions also had
more frequent episodes of biopsy-documented
acute rejection (3.0%, 15.7%, and 13.4%, v2,
p < 0.01).
Long-term clinical outcomes
There were four cases of death and/or kidney fail-
ure within 30 d. They were excluded from subse-
quent survival analyses. During follow-up, 147
patients died and 80 kidney grafts were lost (death
censored). The most common causes of death were
CVE (37.4%), infections (27.9%), and malignan-
cies (10.2%). However, a large fraction of death
had unknown or otherwise non-speciﬁed causes
(25.4%). The predominant causes of graft loss
were acute and/or chronic rejection (75.0%) fol-
lowed by infectious (7.5%) and other/or non-speci-
ﬁed causes (17.5%). Patients who had early
readmissions displayed inferior clinical outcomes,
deﬁned as patient (Fig. 2A, log-rank, p < 0.001)
and death-censored kidney survival (Fig. 2B, log-
rank, p < 0.001). Cox proportional regression
analyses, either univariate or multivariate models
adjusting for various demographic characteristics,
as well as baseline renal function achieved and
occurrence of biopsy-documented early acute rejec-
tion, conﬁrmed the statistically signiﬁcant associa-
tion between frequent hospital readmissions (twice
or more) and increased risk of death and death-
censored kidney failure: a 75% increase in the risk
of death (AHR 1.75, 95% CI 1.19, 2.59, p = 0.01
for frequent readmissions) and more than 100%
increase in the risk of death-censored kidney fail-
ure (AHR 2.20, 95% CI 1.33, 3.64, p < 0.01 for
frequent readmissions; Table 3), respectively.
Numerically, more patients from zero readmission
group than from isolated and frequent readmission
groups died of CVE (42.0% vs. 33.3% and 23.5%,
respectively), and more patients from readmission
groups (isolated and frequent) than from zero re-
admission group died of infectious causes (33.3%
and 35.3%, respectively, vs. 23.9%). However,
these diﬀerences were not statistically signiﬁcant
(p = 0.47). Similarly, no signiﬁcant diﬀerence was
found in the causes of kidney graft loss among the
groups although more patients from frequent read-
mission group lost kidney due to infection (21.4%
vs. 12.5% and 2.0% among patients with isolated
and zero readmission, respectively, p = 0.09).
Additional variables associated with an
increased risk of death included old patient age,
longer dialysis vintage, presence of diabetes mell-
itus as comorbidity, a history of alcohol abuse and
chronic opioid usage prior to transplantation, and
longer initial hospital stay at transplantation. Hav-
ing a higher baseline renal function, on the other
hand, was associated with lower risk of death.
Finally, an increased risk for death-censored
kidney failure was observed for AA patients,
patients with a positive smoking history, and
patients who had DGF, whereas old patient age,
receiving ﬁrst transplant, having higher baseline
renal function and private health insurance were
associated with a reduced risk for death-censored
kidney failure (Table 3).
Discussion
The present study shows that unplanned hospital
readmissions following index kidney transplanta-
tion are very common early post-transplantation
and negatively associated with both short- and
long-term post-transplant clinical outcomes. In
particular, frequent hospital readmissions, twice or
more, during the initial 30 d were associated with
Fig. 1. Causes of early readmission among patients with iso-
lated or frequent readmissions during the ﬁrst 30 d.
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75% higher risk of death and more than 100%
higher risk of death-censored kidney failure.
Kidney transplantation is considered an elective
surgical procedure given the availability of dialysis
for patients with end-stage renal disease. Neverthe-
less, this elective surgical procedure faces unique
challenges as the patient population served by kid-
ney transplantation often carries signiﬁcant burden
of medical and/or surgical comorbidities including
diabetes mellitus, hypertension, coronary artery
disease, and peripheral vascular occlusive disease.
These patients also require long-term use of immu-
nosuppressive medications post-transplantation,
which in turn can lead to various adverse eﬀects
ranging from infections to metabolic de-arrange-
ments and malignancy (17–19). Our observed read-
mission rate of 36% during the initial 30 d is close
to the 31% overall early hospital readmission rate
reported recently by McAdams-DeMarco et al.
using national data (6). Similarly, the reasons for
readmissions, observed in our study that included
surgical complications, infection, acute kidney
injuries/acute rejection, and CVE, are also in line
with their ﬁndings as well as other previous reports
and consistent with the nature of the index hospi-
talization, the overall state of immunosuppression,
and the increased cardiovascular burden of kidney
transplant patients (5–7, 12, 14). The presence and
severity of these comorbidities likely aﬀect the risk
for readmissions, as evidenced by studies involving
both general and kidney transplant patient popula-
tion, although the practice patterns of individual
hospitals (a center eﬀect) could inﬂuence the read-
mission rates as well (1, 6, 20, 21). There was no
signiﬁcant diﬀerence in the pattern for the reasons
of readmission between patients with isolated and
frequent early readmission, although numerically,
surgical complication and infection contributed
more to the frequent readmission early after trans-
plantation. Furthermore, we observed positive
association between various demographic and
baseline characteristics and the readmissions.
Some of them were similar to those reported by
the previous studies such as length of initial hospi-
tal stay, AA race, and receiving an ECD kidney,
whereas others were not, like a pre-transplant
history of reported psychiatric conditions and
smoking habit. It remains unclear why patients
with a positive psychiatric history were more likely
to have frequent readmissions. After a detailed
review, only ﬁve readmissions among four patients
were related psychological diagnosis as the
primary reason. During subsequent follow-up, a
positive history of psychiatric illness was not asso-
ciated with increased risk of death or kidney graft
loss (data not shown).
Table 2. Predictors of early hospital read-
missionsa
Variables
Once Twice or more
AOR 95% CI p AOR 95% CI p
Initial hospital stay, d 1.08 1.04, 1.12 <0.01 1.07 1.02, 1.12 0.01
Psychiatric history, yes 1.24 0.88, 1.74 0.22 2.45 1.53, 3.92 <0.01
African American, yes 1.65 1.13, 2.42 0.01 1.98 1.15, 3.39 0.01
ECD, yes 1.94 1.27, 2.96 <0.01 1.21 0.63, 2.36 0.57
Smoking history, yes 1.48 1.07, 2.03 0.02 1.52 0.95, 2.44 0.08
AOR, adjusted odds ratios; ECD, expanded criteria donors.
aPatients with no readmission as reference group.
A
B
Fig. 2. Kaplan–Meier conditional survival analysis: (A)
patient survival and (B) death-censored kidney survival.
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We observed lower achieved baseline renal func-
tion and higher incidence of acute rejection during
the early periods among patients who required
hospital readmissions. It is possible that conditions
leading to hospital readmissions could be either
related to poorer renal function/acute rejection or
contribute to poorer renal function. An interesting
and potentially useful observation derived from
our study, however, is the independent negative
association of frequent rather than isolated early
readmissions post-transplantation with future clin-
ical outcomes. There could be at least two possible
explanations for this ﬁnding. First, the conditions
that led to frequent early readmissions were
directly responsible for subsequent occurrence of
clinical events. The ﬁnding of higher numbers of
death and kidney graft loss as a result of infection
among patients with isolated and/or frequent early
readmissions would support such speculation
although relatively lower numbers of events (death
and/or graft loss) likely prevented a statistically
meaningful comparison. Alternatively, patients
who required frequent early hospital readmissions
had underlying medical, surgical, and social condi-
tions that increased the risk for future clinical
events. Our ﬁndings would suggest that frequent
hospital readmissions early after transplantation
can be a marker of increased risk for inferior long-
term transplant outcomes and that infection, as a
cause for readmission, likely played a major detri-
mental role. More studies are needed to conﬁrm
our observations and to investigate the utility of
interventions such as dedicate and individualized
predischarge planning, post-discharge telephone
call, timely follow-up appointment in the outpa-
tient clinic, and prompt referral to specialist clinics
such as infectious disease and cardiology clinics,
etc. for patients who required frequent early read-
missions as means to improve long-term outcomes
(4).
Among other baseline variables, we found
unique negative association between a positive his-
tory of alcohol abuse and chronic opioid usage
prior to transplantation and risk of death, as we
reported previously (22). On the other hand, we
did not ﬁnd any negative impact of early acute
rejection on the long-term clinical outcomes, either
in univariate or multivariate analyses, with and/or
without early hospital readmissions in the model.
We speculate that early episodes of acute rejection
were more likely diagnosed promptly, treated
accordingly and eﬀectively.
Our study has several limitations. First, it is a
retrospective observational study, and thus, a cau-
sal relationship between various variables exam-
ined in the study and the frequency of hospital
readmissions and undesirable clinical outcomes
cannot be ascertained by the study design. Second,
although a speciﬁc diagnosis was identiﬁed for
each readmission, such diagnoses may not be the
Variables
Death Graft failure
HR 95% CI p HR 95% CI p
Early readmission a,b
Once 1.56 1.16, 2.10 0.01 ns
Twice or more 2.21 1.49, 3.26 0.01 2.49 1.50, 4.14 0.01
Early readmission a,c
Once ns ns
Twice or more 1.75 1.19, 2.59 0.01 2.20 1.33, 3.64 <0.01
eGFR, mL/min 0.99 0.98, 1.00 0.01 0.97 0.96, 0.98 <0.01
Recipient age, yr 1.05 1.04, 1.07 <0.01 0.98 0.96, 0.99 <0.01
Dialysis duration, yr 1.07 1.02, 1.13 0.01 ns
African American, yes ns 1.89 1.27, 2.80 <0.01
Diabetes mellitus, yes 2.35 1.81, 3.05 <0.01 ns
History of alcohol abuse, yes 1.72 1.23, 2.41 <0.01 ns
History of opioid usage, yes 1.57 1.09, 2.27 0.02 ns
Initial hospital stay, d 1.04 1.01, 1.06 <0.01 ns
First transplant, yes ns 0.42 0.28, 0.63 <0.01
Private health insurance, yes ns 0.59 0.41, 0.87 0.01
Delayed graft function, yes ns 1.57 1.02, 2.42 0.04
Positive smoking history, yes ns 1.72 1.20, 2.46 <0.01
ns, not significant.
aPatients with no readmission as reference group.
bUnivariate analysis.
cMultivariate analysis including only baseline characteristic with p ≤ 0.10 in univariate analysis.
Table 3. Association between early read-
missions, various baseline characteristics,
and risk of death and death-censored kid-
ney graft failure
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primary or only reason for readmission as individ-
ual physicians may use diﬀerent readmission crite-
ria and possess diﬀerent thresholds for hospital
admission for patients with a similar diagnosis.
Third, as both patient and center eﬀects play an
important role in determining early hospital read-
mission rate (6), the generalizability of a single-cen-
ter experience such as ours remains uncertain.
Fourth, many of the pre-transplant baseline infor-
mation were self-reported by patients during the
transplant evaluation process, such as habit of
illicit drug and/or chronic opioid use, psychiatric
conditions, etc.; thus, caution should be taken at
interpreting any positive association with out-
comes observed in our study. Finally, while all
patients received their transplant surgery in our
hospital, our measurement of readmission may not
represent the readmission rate for each patient as
some patients may have been admitted to commu-
nity hospitals for kidney-related or no medical
problems that were not captured in our dataset.
This study will require replication, possibly using
larger regional or national data adjusting for the
center eﬀects (such as transplant volume, geo-
graphic location, etc.), if we are to determine clini-
cal interventions that address the population of
kidney transplant patients who experience frequent
early readmissions for transplant-related surgical
and/or medical complications to promote more
positive long-term clinical outcomes.
In summary, frequent hospital readmissions
within 30 d post-kidney transplantation identify
kidney transplant patients at risk for future nega-
tive clinical outcomes. More studies are needed
to conﬁrm our observation and to understand
the underlying mechanisms of this negative associ-
ation.
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